Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rank in Stocks
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Share Price
$3.89
Market Cap
$3.30B
Change (1 day)
-3.14%
Change (1 year)
43.11%
Country
CN
Trade Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Category
Healthcare
Revenue for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Revenue in Jun 2026 TTM: $332.95M
According to Guangdong Zhongsheng Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is $332.95M. In 2024 the company made a revenue of $338.04M a decrease compared to the revenue in the year 2023 that was $368.79M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Guangdong Zhongsheng Pharmaceutical Co., Ltd. from 2006 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $332.95M | -7.66% |
| 2025 | $360.58M | 6.67% |
| 2024 | $338.04M | -8.34% |
| 2023 | $368.79M | -4.94% |
| 2022 | $387.97M | 1.51% |
| 2021 | $382.18M | 31.69% |
| 2020 | $290.21M | -20.17% |
| 2019 | $363.55M | 5.90% |
| 2018 | $343.31M | 13.72% |
| 2017 | $301.90M | 23.85% |
| 2016 | $243.77M | 0.33% |
| 2015 | $242.96M | 15.01% |
| 2014 | $211.26M | 17.56% |
| 2013 | $179.70M | 26.42% |
| 2012 | $142.15M | 19.38% |
| 2011 | $119.07M | 22.66% |
| 2010 | $97.07M | 20.15% |
| 2009 | $80.79M | 13.84% |
| 2008 | $70.98M | 28.15% |
| 2007 | $55.38M | 32.26% |
| 2006 | $41.88M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $23.54B | 6,968.81% |
DE
|
|
| $23.73B | 7,028.77% |
DE
|
|
| $29.24B | 8,682.09% |
JP
|
|
| $5.85B | 1,656.66% |
CH
|
|
| $6.61B | 1,885.80% |
IN
|
